Strategic News Watch • September 24, 2026 Daily Biopharma Digest – September 24, 2026 September 24, 2026 The FDA cleared Lilly’s once-weekly basal insulin Onswik… Pro Hub Membership Required You must be a Pro Hub member to access this content. Join Now Already a member? Log in here